Article
Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma.
The European respiratory journal - 1 Feb 2012
Girard N, Sima C S, Jackman D M, Sequist L V, Chen H, Yang J C-H, Ji H, Waltman B, Rosell R, Taron M, Zakowski M F, Ladanyi M, Riely G, Pao W
Abstract excerpt
Epidermal growth factor receptor (EGFR) tumour genotyping is crucial to guide treatment decisions regarding the use of EGFR tyrosine kinase inhibitors in nonsmall cell lung cancer (NSCLC). However, some patients may not be able to obtain tumour testing, either because tissue is limited and/or tests are not routinely offered. Here, we aimed to build a model-based nomogram to allow for prediction of the presence of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.